MEDIFUSION: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDIFUSION
Largest movements
- Receivables within one year -€1,504
no longer reported in 2023 (was €1,504)
- Tangible fixed assets -€255
down €255 (-25.0%), from €1,021 to €766
- Cash -€164
down €164 (-83.2%), from €197 to €33
mainly Tax, wage and social debts (-€5,791) and Other debts (-€63)
- Tax, wage and social debts -€5,791
no longer reported in 2023 (was €5,791)
- Profit (loss) carried forward +€3,734
up €3,734 (+75.7%), from -€4,932 to -€1,198
- Reserves +€197
new in 2023: €197
- Other debts -€63
no longer reported in 2023 (was €63)
- Gross operating margin +€24,628
up €24,628 (+286%), from €8,623 to €33,251
- Staff costs +€16,152
up €16,152 (+126%), from €12,780 to €28,932
From the 2022 result to the 2023 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2022 and 2023 balance sheets and the 2023 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2022 | 2023 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,722 | €799 | -€1,923 | -70.6% |
| Fixed assets | 21/28 | €1,021 | €766 | -€255 | -25.0% |
| Tangible fixed assets | 22/27 | €1,021 | €766 | -€255 | -25.0% |
| Furniture and vehicles | 24 | €1,021 | €766 | -€255 | -25.0% |
| Current assets | 29/58 | €1,701 | €33 | -€1,668 | -98.1% |
| Amounts receivable within one year | 40/41 | €1,504 | - | -€1,504 | |
| Other amounts receivable | 41 | €1,504 | - | -€1,504 | |
| Cash at bank and in hand | 54/58 | €197 | €33 | -€164 | -83.2% |
| Total equity and liabilities | 10/49 | €2,722 | €799 | -€1,923 | -70.6% |
| Equity | 10/15 | -€3,132 | €799 | +€3,931 | |
| Contributions | 10/11 | €1,800 | €1,800 | = | 0.0% |
| Capital | 10 | €1,800 | €1,800 | = | 0.0% |
| Issued capital | 100 | €1,800 | €1,800 | = | 0.0% |
| Reserves | 13 | - | €197 | +€197 | |
| Non-distributable reserves | 130/1 | - | €197 | +€197 | |
| Legal reserve | 130 | - | €197 | +€197 | |
| Profit (loss) carried forward | 14 | -€4,932 | -€1,198 | +€3,734 | +75.7% |
| Amounts payable | 17/49 | €5,854 | - | -€5,854 | |
| Amounts payable within one year | 42/48 | €5,854 | - | -€5,854 | |
| Taxes, remuneration and social security | 45 | €5,791 | - | -€5,791 | |
| Taxes | 450/3 | €5,791 | - | -€5,791 | |
| Other amounts payable | 47/48 | €63 | - | -€63 | |
| Remuneration, social security and pensions | 62 | €12,780 | €28,932 | +€16,152 | +126% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €255 | €255 | = | 0.0% |
| Non-recurring operating charges | 66A | €409 | - | -€409 | |
| Gross operating margin | 9900 | €8,623 | €33,251 | +€24,628 | +286% |
| Operating profit (loss) | 9901 | -€4,821 | €4,064 | +€8,885 | |
| Financial income | 75/76B | - | €0 | = | |
| Recurring financial income | 75 | - | €0 | = | |
| Financial charges | 65/66B | €111 | €133 | +€22 | +19.8% |
| Recurring financial charges | 65 | €111 | €133 | +€22 | +19.8% |
| Profit (loss) for the period before taxes | 9903 | -€4,932 | €3,931 | +€8,863 | |
| Profit (loss) for the period | 9904 | -€4,932 | €3,931 | +€8,863 | |
| Profit (loss) for the period to be appropriated | 9905 | -€4,932 | €3,931 | +€8,863 |
Source: filed annual accounts (NBB), financial years ended 31 December 2022 and 31 December 2023. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 14 October 2026 via checked.be.